Stay updated on Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1 from the Study Record Versions.SummaryDifference0.1%

- Check32 days agoChange DetectedNew revision entry v3.3.1 was added and an older revision v3.2.0 was removed, updating the record's version history; this is a minor metadata change that does not affect study details. "To avoid being alerted by small changes, set an alert condition by clicking below."SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding/operating status notice banner from the page. This change does not affect the study data or current details displayed.SummaryDifference0.8%

- Check53 days agoChange DetectedThe Record History page for NCT04280328 shows the version list and status fields; no additions or deletions were detected in the new screenshot.SummaryDifference0.1%

- Check82 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference13%

Stay in the know with updates to Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page.